Trials / Completed
CompletedNCT02730689
A Study to Compare the Pharmacokinetics of DP-R207 in Comparison to Each Component Administered Alone
A Randomized, Single-dose, Open, Crossover Clinical Trial to Compare the Pharmacokinetics of DP-R207 in Comparison to Each Component Administered Alone in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 66 (actual)
- Sponsor
- Alvogen Korea · Industry
- Sex
- Male
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare the pharmacokinetics of DP-R207 (Rosuvastatin 10mg and Ezetimibe 10mg fixed dose combinations) in comparison to each component administered alone in health male volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DP-R207 | |
| DRUG | Rosuvastatin | |
| DRUG | Ezetimibe |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2015-01-01
- Completion
- 2015-01-01
- First posted
- 2016-04-06
- Last updated
- 2016-04-06
Source: ClinicalTrials.gov record NCT02730689. Inclusion in this directory is not an endorsement.